Koyfin Home > Directory > Health Care > Antares Pharma > Price / Book

Antares Pharma Price / Book Chart (ATRS)

Antares Pharma annual/quarterly Price / Book from 2001 to 2018. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
  • Antares Pharma Annual Price / Book for 2017 was 8.65 a 14.80% increase of 1.28 from 2016
  • Antares Pharma Annual Price / Book for 2016 was 7.37 a 64.99% increase of 4.79 from 2015
  • Antares Pharma Annual Price / Book for 2015 was 2.58 a -160.08% decrease of -4.13 from 2014
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
View Chart On Koyfin

Quarterly ATRS Price / Book Data

03/201810.27
12/20178.65
09/201712.57
06/201712.09
03/20179.75
12/20167.37
09/20164.78
06/20162.72
03/20162.01
12/20152.58

Annual ATRS Price / Book Data

20178.65
20167.37
20152.58
20146.71
20137.70
201211.72
20117.37
201020.34
20098.52
20082.59